Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Pocket

Financiado

Cerrado

Development of a low cost point of care test for Tuberculosis detection

Pocket will develop a novel point-of-care (PoC) urine test for the detection of tuberculosis (TB), achieving at the same time a low cost (5 to 10 euro end-user cost per test, including depreciation cost of the instrument) and a hi... ver más

30/04/2017

UGent

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-04-30 No tenemos la información de la convocatoria

0% 76% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

UGent

0.00€ | Lider

TRINEAN NV

N.D. | Participante

MICROFLUIDIC

N.D. | Participante

Proyectos interesantes

RAPID UTI

Medical Technol...

Medical Devices

75K€ Cerrado

mfloDx

Medical Technol...

Data Science

71K€ Cerrado

TOPO-TB

Medical Technol...

Health Informat...

71K€ Cerrado

RAPP-ID

Medical Technol...

Data Science

16M€ Cerrado

ARREST-TB

Medical Technol...

Data Science

4M€ Cerrado

AMPD

Medical Technol...

Data Science

173K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Pocket will develop a novel point-of-care (PoC) urine test for the detection of tuberculosis (TB), achieving at the same time a low cost (5 to 10 euro end-user cost per test, including depreciation cost of the instrument) and a high accuracy (>80% capture of TB-positive patients, which is much better than the present solutions which reach 60%). The test positions itself between current low-end immunological urine tests with limited accuracy and between high-end expensive nucleic-acid-based tests, which are not truly point-of-care. Throughout this project, special attention will be paid to both end-user requirements (performance, cost, ease-of-use, ...) and to manufacturability. Pocket will go well beyond the development of a mere laboratory prototype, as in the final year of the project, the instrument will be field-tested in Africa and India.<br/>The combination of low cost and high accuracy will be achieved through a unique integration of several state-of-the-art concepts, which the partners have separately developed and of which the maturity has already been shown:<br/>-a nanophotonic transducer with integrated spectrum analyser developed by UGent (Vernier ring resonator cascade with arrayed waveguide grating spectrometer). This will enable us to eliminate the cost associated with the inclusion of a high-end tunable laser (20k euro) that typically plagues the competing approaches using resonant optical nanophotonic sensors.<br/>-a high-confinement silicon nitride (SiN) platform running in a mature small-volume CMOS fab (imec). The use of SiN as opposed to the more traditional Silicon-on-Insulator material system will enable us to move the operating wavelength from 1550 nm to 900 nm, where both the sources and the detectors are significantly less expensive.<br/>-a novel TB detection system, based on a unique combination of high-quality antibodies for two different biomarkers.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores